Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Repurposing dihydroartemisinin as a novel anticancer agent against colorectal cancer stem cells
Saved in:
| Published in: | Journal of Food and Drug Analysis |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2025
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Repurposing dihydroartemisinin as a novel anticancer agent against colorectal cancer stem cells
- In silico Drug Repurposing of Anticancer Drug 5-FU and Analogues Against SARS-CoV-2 Main Protease: Molecular Docking, Molecular Dynamics Simulation, Pharmacokinetics and Chemical Reactivity Studies
- Autocrine motility factor peptide enhances curcumin/tetrahydrocurcumin activity against colorectal cancer cells in association with glucose-6-phosphate dehydrogenase downregulation and oxidative stress
- Correction to ‘Cabazitaxel suppresses colorectal cancer cell growth via enhancing the p53 antitumor pathway’
- Identifying gene expression signatures for risk stratification of postoperative adjuvant chemotherapy in colorectal cancer
- Pyrazoline B-Paclitaxel or Doxorubicin Combination Drugs Show Synergistic Activity Against Cancer Cells: In silico Study
- Targeting TNBC: core–shell polycationic polyurea dendrimers with inherent anticancer activity